Acinetobacter infection in neurosurgical intensive care patients.

dc.contributor.authorSuri, Aen_US
dc.contributor.authorMahapatra, A Ken_US
dc.contributor.authorKapil, Aen_US
dc.date.accessioned2000-11-24en_US
dc.date.accessioned2009-06-03T06:17:19Z
dc.date.available2000-11-24en_US
dc.date.available2009-06-03T06:17:19Z
dc.date.issued2000-11-24en_US
dc.description.abstractBACKGROUND: This study was performed to analyse the incidence of Acinetobacter infections in neurosurgical patients in the postoperative period. METHODS: Two thousand three hundred and twenty postoperative cranial neurosurgical intensive care unit (ICU) patients were studied from March 1995 to August 1996; 419 patients had a variety of infections and 42 patients had multiple infections. Acinetobacter was isolated in 103 patients (24.6% of total patients infected and 4.4% of total patients analysed). Statistical analyses were performed to identify the risk factors, antibiotic sensitivity and outcome of therapy of Acinetobacter infection. RESULTS: Acinetobacter infection was not significantly related to the length of hospital stay prior to surgery but was related significantly to the length of stay in the ICU after surgery. Acinetobacter was isolated from sputum/tracheal secretions in 47/103 (45.6%), followed by cerebrospinal fluid [24/103 (23.3%)], urine [15/103 (14.56%)] and blood [15/103 (11.65%)]. Acinetobacter infection was present in 54 (3.21%) of 1680 patients who had undergone routine/elective surgery and in 49 (7.66%) of 640 patients following emergency surgery. Elective/supportive ventilation for > 5 days, external ventricular cerebrospinal fluid drainage for > 5 days, intracranial pressure monitoring and prolonged indwelling Foley's urinary catheter during the perioperative period were independent risk factors (p < 0.005). Acinetobacter isolated from sputum/tracheal secretions were mostly sensitive to amikacin, cefotaxime and ceftriaxone; while those grown from the cerebrospinal fluid were more often sensitive to ciprofloxacin, amikacin and netilmycin. Twenty-four patients succumbed to Acinetobacter infection; in 11 of these patients the organism was resistant to all antibiotics. CONCLUSION: Acinetobacter is an important nosocomial infection in neurosurgical intensive care patients.en_US
dc.identifier.citationSuri A, Mahapatra AK, Kapil A. Acinetobacter infection in neurosurgical intensive care patients. National Medical Journal of India. 2000 Nov-Dec; 13(6): 296-300en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/118944
dc.language.isoengen_US
dc.source.urihttps://www.nmji.inen_US
dc.subject.meshAcinetobacter Infections --epidemiologyen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshCross Infection --epidemiologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIndia --epidemiologyen_US
dc.subject.meshInfanten_US
dc.subject.meshIntensive Care Units --statistics & numerical dataen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeurosurgical Proceduresen_US
dc.subject.meshPostoperative Complications --epidemiologyen_US
dc.subject.meshRisk Factorsen_US
dc.titleAcinetobacter infection in neurosurgical intensive care patients.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: